Notably, KMT2D-deficient lung cancer cells depend on proper glycolytic activities for survival [117], which is compatible with the notion that loss of TFB1M may be lethal for KMT2D-deficient cells. The gene discussed is TFB1M; the disease is lung carcinoma.